Código QR (código de barras bidimensional)

The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study

Abstract Objective Dual‐antiplatelet therapy (DAPT) and proton pump inhibitor (PPI) are frequently prescribed after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) placement. However, studies that evaluate the optimal PPI when used as primary prevention in patients without a...

ver descrição completa

Na minha lista:
Principais autores: Yutaro Ide, Go Morikawa, Kyohei Yoshida, Yuki Takano, Ken Kubota, Katsuko Okazawa, Takeo Yasu
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2024-11-01
coleção:Journal of Pharmaceutical Health Care and Sciences
Assuntos:
PCI
DAPT
PPI
UGBI
Prasugrel
Lansoprazole
Acesso em linha:https://doi.org/10.1186/s40780-024-00398-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados